Vermillion trades as part of the medical diagnostics and research industry and trades as part of the healthcare sector. The company CEO is Valerie Palmieri. Vermillion Inc is engaged in discovery, development, and commercialization of novel high-value diagnostic tests that help physicians diagnose, treat and improve outcomes for patients with gynecologic cancers and related diseases.



Previous Intraday Performance:

The VRML shares had a previous change of 0.89% which opened at 1.12 and closed at 1.13. It moved to an intraday high of 1.18 and a low of 1.11.

SeekingAlpha:  Vermillion’s (VRML) CEO Valerie Palmieri on Q1 2019 Results – Earnings Call Transcript

Historical Performance:

Over the last five trading days, VRML shares returned -8.13% and in the past 30 trading days it returned -1.74%. Over three months, it changed 60.28%. In one year it has changed 10.78% and within that year its 52 week high was 1.57 and its 52 week low was 0.27. VRML stock is 318.36% above its 52 week low.

Our calculations result in a 200 day moving average of 0.77 and a 50 day moving average of 1.25. Right now, VRML stock is trading 46.97% above its 200 day moving average.

SeekingAlpha:  Vermillion reports Q1 results

Liquidity:

The company has a market cap of $86.2m with 75.6m shares outstanding and a float of 65.9m shares. Trading volume was 9,547 shares and has experienced an average volume of 85,447 shares. Our calculation, using the current average volume and close price, leads me to believe that the liquidity is bad, highly speculative and an investor may want to avoid this stock.

Earnings:

The last annual reported EPS for Vermillion was -0.16 which ended on 31st of December 2018.

1stQtr 2019 -0.054thQtr 2018 -0.043rdQtr 2018 -0.042ndQtr 2018 -0.041stQtr 2018 -0.05

EPS growth is an important number as it indicates the future prospects of Vermillion; it is usually expressed as a percentage and is then referred to as the EPS growth rate, which at this time is hard to estimate, but revenue growth has been -17.30% over the last twelve months.

Indicators Also to Watch:

Based on the latest filings, there is 22.40% of institutional ownership.

The beta was calculated to be 3.67.



SeekingAlpha:  Vermillion reports Q1 results

Fundamental Numbers:

Based on last reported financials, the company’s return on equity is -513.56%, return on assets is -185.19%, price-to-sales is 27.57 and price-to-book is 24.31.

Company Score Card:

Results are out of six:
 0  : Growth Expectations Result
 3  : Financial Safety Result
 0  : Past Performance Result
 0  : Valuation Result
 0  : Dividend Safety Result
 0  : Overall Result

Related Tags: , , ,

Jake McWilliams
I am an independent trader, analyst and algorithmic trading expert, having worked both for the sell side (brokerage) and the buy side (fund administration). I have been trading professionally for about 20 years. I trade stocks and forex and I play both long and short positions in underlying asset or through options. I have experience with discretionary and fully automated systems (Metatrader and Quantshare).

LEAVE A REPLY

Please enter your comment!
Please enter your name here